IL10 and autoimmune disease: As previous studies have indicated that IL-10 secreting plasma cells or plasmablasts may play a regulatory role in autoimmune diseases (28, 29), a decrease in IL-10 production by NOD.Ifih1R/R CD138+ cells may support enhanced inflammation during diabetes.